2018
DOI: 10.1016/j.pt.2018.05.001
|View full text |Cite
|
Sign up to set email alerts
|

Ten Events That Defined Anthelmintic Resistance Research

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
58
0
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
3
2
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 87 publications
(66 citation statements)
references
References 43 publications
0
58
0
2
Order By: Relevance
“…Although it is not widespread, resistance has already developed to two new active ingredients, monepantel and derquantel. This was despite spiroindole-derquantel-being marketed as a combination product to slow the development of resistance [48]. All of these highlight the urgent need to identify risk factors associated with AR development, to inform future recommendations on sustainable parasite control [49].…”
Section: Anthelmintic Resistancementioning
confidence: 99%
See 2 more Smart Citations
“…Although it is not widespread, resistance has already developed to two new active ingredients, monepantel and derquantel. This was despite spiroindole-derquantel-being marketed as a combination product to slow the development of resistance [48]. All of these highlight the urgent need to identify risk factors associated with AR development, to inform future recommendations on sustainable parasite control [49].…”
Section: Anthelmintic Resistancementioning
confidence: 99%
“…Development of AR can be limited by ensuring that the parasites are exposed to an effective drug dose and to consider the timing and frequency of anthelmintic drug treatments so that only a small proportion of the population is exposed to the anthelmintic [51]. The main factors for the selection for anthelmintic resistance are high-treatment frequency, [52] underdosing and the use of the same anthelmintic class over several years [48]. These factors, individually or in combination, together with the risk of underdosing and continued use of one class of anthelmintics, irrespective of efficacy status are frequently encountered factors enhancing development of anthelmintic resistance [53].…”
Section: Risk Factors For Development Of Armentioning
confidence: 99%
See 1 more Smart Citation
“…This has resulted in the selection for AR in nematodes against the main groups of anthelmintics, the benzimidazoles (BZs), the imidazothiazoles/tetrahydropyrimidines and the macrocylic lactones (MLs) and across multiple GIN species [12][13][14]. Currently, AR against BZs is the most common form, but the prevalence of multi-drug resistance is increasing [15][16][17]. New anthelmintics such as derquantel and monepantel have been developed, however, resistance against monepantel has already been described only two years after its introduction [18].…”
Section: Introductionmentioning
confidence: 99%
“…A.suum and is rising in human populations (reviewed in Sangster et al, 2018), this will prove 400 critical in the control and treatment of these major pathogens. 401…”
mentioning
confidence: 99%